Forced Degradation of Therapeutic Proteins
Top Cited Papers
- 1 March 2012
- journal article
- review article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 101 (3), 895-913
- https://doi.org/10.1002/jps.22812
Abstract
No abstract availableKeywords
This publication has 150 references indexed in Scilit:
- Classification and Characterization of Therapeutic Antibody AggregatesJournal of Biological Chemistry, 2011
- Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress ConditionsJournal of Biological Chemistry, 2011
- Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product DevelopmentPharmaceutical Research, 2010
- Monoclonal antibody interactions with micro- and nanoparticles: Adsorption, aggregation, and accelerated stress studiesJournal of Pharmaceutical Sciences, 2009
- Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous SolutionJournal of Pharmaceutical Sciences, 2009
- Shear-Induced Unfolding of Lysozyme Monitored In SituBiophysical Journal, 2009
- Towards Heat-stable Oxytocin Formulations: Analysis of Degradation Kinetics and Identification of Degradation ProductsPharmaceutical Research, 2009
- Response of a concentrated monoclonal antibody formulation to high shearBiotechnology & Bioengineering, 2009
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Is any measurement method optimal for all aggregate sizes and types?The AAPS Journal, 2006